SCHEMBL2360182

SCHEMBL2360182

O=Cc1cccc(-c2ccc(Cl)cc2)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 4/20 0.44
PTGS2 P35354 2/20 0.40
PTGS1 P23219 1/20 0.40
SUCNR1 Q9BXA5 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
THRB P10828 1/20 0.38
BLM P54132 1/20 0.38
KMT2A Q03164 1/20 0.38
NR4A2 P43354 1/20 0.37
XDH P47989 2/20 0.37
NFE2L2 Q16236 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2359029 0.85 ERN1 (0.44) ERN1PTGS2PTGS1TDP1MEN1
SCHEMBL14879484 0.83 TDP1 (0.44) ERN1PTGS2PTGS1HSD17B10TDP1
SCHEMBL387189 0.82 XDH (0.51) ERN1PTGS2PTGS1HSD17B10TDP1
SCHEMBL16399564 0.82 LMNA (0.48) ERN1TDP1MEN1LMNATHRB
SCHEMBL15742298 0.81 ERN1 (0.48) ERN1TDP1MEN1LMNATHRB
SCHEMBL9990065 0.81 PTGS2 (0.40) ERN1PTGS2PTGS1HSD17B10TDP1
SCHEMBL5735298 0.80 ERN1 (0.52) ERN1PTGS2PTGS1HSD17B10SLC6A4
SCHEMBL547471 0.80 PTGS2 (0.39) ERN1PTGS2PTGS1HSD17B10TDP1
SCHEMBL12523784 0.80 ERN1 (0.36) ERN1TDP1MEN1LMNATHRB
SCHEMBL2064769 0.79 NR4A2 (0.69) NR4A2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094890-A1 PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS ARGUSINA INC. (US) 2011-08-11 WO disclosed